Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unlocking nature's cure: utilizing Indian and Chinese medicinal plants as CDK inhibitors in the p53 pathway of breast cancer.

In silico pharmacology·2026
Same author

A mechanistic axis of shear stress, reactive oxygen species, and microRNAs underlying endothelial dysfunction in myocardial infarction.

Molecular biology reports·2026
Same author

Exploring Therapeutic and Multitarget Mechanism of Molsidomine on Cerebral Ischemia: Molecular Docking and Multifaceted In Silico Study.

Advances in experimental medicine and biology·2025
Same author

CANDiT: A machine learning framework for differentiation therapy in colorectal cancer.

Cell reports. Medicine·2025
Same author

Indian medicinal phytocompounds for targeting apoptosis and high-penetrance genes in triple-negative breast cancer: an in-silico exploration.

BMC molecular and cell biology·2025
Same author

Bridging molecular insights and clinical application: non-coding RNAs, targeted drug delivery, and metastatic breast cancer therapy.

Discover oncology·2025
Same journal

Tracking Synthetic Adhesins on Bacterial Surfaces with Immunofluorescence Microscopy.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Post-Selection Methods for Analyzing mRNA Display Selections and Optimization of Hits.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

High-Performance Computing in Tandem Mass Spectrometry (MS/MS) Peptide Identification.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Engineering and Adapting Disulfide-Containing Proteins to Enable Intracellular Functionality.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

AI-Driven Protein Research: From Prediction to Design.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Methods for the In Vitro Selection of Protein and Peptide Libraries Using mRNA Display.

Methods in molecular biology (Clifton, N.J.)·2026
See all related articles

Related Experiment Video

Updated: Jul 4, 2025

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
17:28

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Published on: June 17, 2015

12.6K

Human Pluripotent Stem Cell-Based Assays to Predict Developmental Toxicity.

Madhura Banerjee1, Aritrika Das1, Prarthana Chatterjee1

  • 1School of BioSciences and Technology, Vellore Institute of Technology, Vellore, India.

Methods in Molecular Biology (Clifton, N.J.)
|January 29, 2024
PubMed
Summary
This summary is machine-generated.

Environmental toxins harm reproductive health and offspring development. Human pluripotent stem cells offer a cost-effective, ethical alternative for developmental toxicity assays, improving prediction accuracy.

Keywords:
Differentiated cellsDifferentiationHuman induced pluripotent stem cellsHuman pluripotent stem cellsTest compounds

More Related Videos

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing
09:02

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing

Published on: June 9, 2017

23.2K
Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions
09:34

Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions

Published on: November 27, 2017

9.3K

Related Experiment Videos

Last Updated: Jul 4, 2025

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
17:28

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Published on: June 17, 2015

12.6K
Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing
09:02

Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing

Published on: June 9, 2017

23.2K
Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions
09:34

Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions

Published on: November 27, 2017

9.3K

Area of Science:

  • Toxicology
  • Developmental Biology
  • Stem Cell Research

Background:

  • Human exposure to environmental toxins impacts reproductive health and offspring development, affecting neurological, cardiac, and musculoskeletal systems.
  • Rising prevalence of birth defects necessitates improved methods for detecting developmental toxicity.
  • Conventional toxicity assays using animal models are expensive, ethically problematic, and have limited predictive value due to interspecies variation.

Purpose of the Study:

  • To provide an overview of methods for predicting compound developmental toxicity using human pluripotent stem cells.
  • To outline an efficient and effective procedure for high-throughput screening of developmental toxicants.
  • To highlight the advantages of human pluripotent stem cells in toxicity testing.

Main Methods:

  • Utilizing human pluripotent stem cells, including induced pluripotent stem cells, for in vitro developmental toxicity assays.
  • Developing and presenting a streamlined protocol for simultaneous screening of multiple compounds.
  • Focusing on assays that leverage the human origin and accessibility of pluripotent stem cells.

Main Results:

  • Human pluripotent stem cells provide a viable alternative to animal models for developmental toxicity testing.
  • The outlined procedure enables simultaneous screening of numerous compounds, increasing efficiency.
  • This approach offers a more predictive and ethically sound method for assessing developmental toxicity.

Conclusions:

  • Human pluripotent stem cells are a superior choice for in vitro developmental toxicity assays due to their accessibility, human origin, and ethical advantages.
  • The presented methodology offers a cost-effective and highly predictive approach to screening for developmental toxicants.
  • Implementing these assays can significantly reduce the occurrence of birth defects linked to toxic substance exposure.